Genes, Locations and Genetic Disorders on Chromosome X

Last Updated: Sun Aug 6 22:00:02 EDT 2000
GeneGDB AccessionIDLocationOMIM Link
ABCD1 GDB:118991Xq28-Xq28 ADRENOLEUKODYSTROPHY; ALD
ACTL1 GDB:119648Xp11.22-Xp11.21 ACTIN-LIKE SEQUENCE-1; ACTL1
ADFN GDB:118977Xq25-Xq26 ALBINISM-DEAFNESS SYNDROME; ADFN; ALDS
AGMX2 GDB:119661Xpter-Xqter AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2; XLA2
AHDS GDB:125899Xq21.1-Xq21.1 Xq21-Xq21 MENTAL RETARDATION, X-LINKED, WITH HYPOTONIA
AIC GDB:118986Xp22-Xp22 CORPUS CALLOSUM, AGENESIS OF, WITH CHORIORETINAL ABNORMALITY
AIED GDB:119663Xp11.4-Xq21 ALBINISM, OCULAR, TYPE 2; OA2
AIH3 GDB:131443Xq22-Xq28 AMELOGENESIS IMPERFECTA-3, HYPOPLASTIC TYPE; AIH3
ALAS2 GDB:119666Xp11.21-Xp11.21 ANEMIA, HYPOCHROMIC
AMCD GDB:5584286Xp11.3-Xq11.2 ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL
AMELX GDB:119675Xp22.31-Xp22.1 AMELOGENESIS IMPERFECTA-1, HYPOPLASTIC TYPE; AIH1
ANOP1 GDB:128454Xpter-Xqter CLINICAL; ANOP1
AR GDB:120556Xq11.2-Xq12 ANDROGEN INSENSITIVITY SYNDROME; AIS
ANDROGEN RECEPTOR; AR
ARAF1 GDB:119004Xp11.3-Xp11.23 V-RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG 1; ARAF1
ARSC2 GDB:119702Xpter-Xqter ARYLSULFATASE C, f FORM; ARSC2
ARSE GDB:555743Xp22.3-Xp22.3 CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1
ARTS GDB:9954651Xq21.2-Xq24 FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION
ASAT GDB:9954649Xq13-Xq13 SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT
ASSP5 GDB:119019Xq22-Xq26 CITRULLINEMIA
ATP7A GDB:119395Xq13.2-Xq13.3 ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A
MENKES SYNDROME
ATRX GDB:136052Xq13.3-Xq13.3 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE
AVPR2 GDB:131475Xq28-Xq28 DIABETES INSIPIDUS, NEPHROGENIC
BFLS GDB:120566Xq26-Xq27.1 BORJESON SYNDROME; BORJ
BGN GDB:119727Xq28-Xq28 BIGLYCAN; BGN
BTK GDB:120542Xq21.33-Xq22 BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
BZX GDB:5205912Xq24-Xq27 BAZEX SYNDROME; BZX
C1HR GDB:119040Xpter-Xqter TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR 2A; TAF2A
CALB3 GDB:133780Xp22.2-Xp22.2 CALBINDIN 3; CALB3
CBBM GDB:9958963Xq28-Xq28 COLORBLINDNESS, BLUE-MONO-CONE-MONOCHROMATIC TYPE; CBBM
CCT GDB:119756Xpter-Xqter Xpter-Xcen CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES;
CDPX2 GDB:125212Xpter-Xqter CHONDRODYSPLASIA PUNCTATA, X-LINKED DOMINANT; CDPX2; CDPXD; CPXD
CDR1 GDB:119053Xq27.1-Xq27.2 CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN-1; CDR1; CDR34
CFNS GDB:9579470Xp22-Xp22 CRANIOFRONTONASAL SYNDROME; CFNS
CGF1 GDB:6275867Xp11.22-Xqter COGNITION
CHM GDB:120400Xq21.1-Xq21.2 Xq21.2-Xq21.2 CHOROIDEREMIA; CHM
CHR39C GDB:119779Xq13-Xq21 CHOLESTEROL REPRESSIBLE PROTEIN 39C; CHR39C
CIDX GDB:127736Xpter-Xqter SEVERE COMBINED IMMUNODEFICIENCY DISEASE, X-LINKED, 2; SCIDX2
CLA2 GDB:119782Xpter-Xqter CEREBELLAR ATAXIA, X-LINKED; CLA2
CLCN5 GDB:270667Xp11.23-Xp11.22 Xp11.22-Xp11.22 CHLORIDE CHANNEL 5; CLCN5
FANCONI SYNDROME, RENAL, WITH NEPHROCALCINOSIS AND RENAL STONES
NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN
CLS GDB:119784Xp22.2-Xp22.1 RIBOSOMAL PROTEIN S6 KINASE, 90 KD, POLYPEPTIDE 3; RPS6KA3
COFFIN-LOWRY SYNDROME; CLS
CMTX2 GDB:128311Xp22-Xp22 CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED RECESSIVE, 2; CMTX2
CMTX3 GDB:128151Xq26-Xq26 Xpter-Xqter CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED RECESSIVE, 3; CMTX3
CND GDB:9954627Xp22.2-Xp22.1 DERMOIDS OF CORNEA; CND
COD1 GDB:119787Xp21.1-Xp11.3 Xp11.4-Xp11.4 CONE DYSTROPHY, X-LINKED, 1; COD1
COD2 GDB:6520166Xq27-Xq27 CONE DYSTROPHY, X-LINKED, 2; COD2
COL4A5 GDB:120596Xq22-Xq22 COLLAGEN, TYPE IV, ALPHA-5 CHAIN; COL4A5
LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY
COL4A6 GDB:222775Xq22-Xq22 COLLAGEN, TYPE IV, ALPHA-6 CHAIN; COL4A6
LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY
CPX GDB:120598Xq21.3-Xq22 Xq21.3-Xq21.3 CLEFT PALATE, X-LINKED; CPX
CSNB1 GDB:119814Xp11.4-Xp11.23 Xp11.3-Xp11.3 NIGHTBLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA; CSNB1
CSNB2 GDB:1347349Xp21.1-Xp21.1 Xp11.23-Xp11.23 NIGHTBLINDNESS, CONGENITAL STATIONARY, X-LINKED, TYPE 2; CSNB2
CVD1 GDB:9954659Xq28-Xq28 CARDIAC VALVULAR DYSPLASIA, X-LINKED
CYBB GDB:120513Xp21.1-Xp21.1 GRANULOMATOUS DISEASE, CHRONIC; CGD
DCX GDB:9823272Xq22.3-Xq23 LISSENCEPHALY, X-LINKED
DFN2 GDB:119091Xq22-Xq22 Xpter-Xqter DEAFNESS, X-LINKED 2, PERCEPTIVE CONGENITAL; DFN2
DFN3 GDB:119842Xq21.1-Xq21.1 DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION
DFN4 GDB:433255Xp21.2-Xp21.2 DEAFNESS, X-LINKED 4, CONGENITAL SENSORINEURAL; DFN4
DFN6 GDB:1320698Xp22-Xp22 DEAFNESS, X-LINKED, 6, PROGRESSIVE; DFN6
DHOF GDB:119847Xpter-Xqter FOCAL DERMAL HYPOPLASIA; DHOF
DIAPH2 GDB:9835484Xq21-Xq21 Xq22-Xq22 DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 2
DKC1 GDB:119096Xq27-Xq28
DYSKERATOSIS CONGENITA; DKC
DMD GDB:119850Xp21.3-Xp21.2 Xp21.2-Xp21.2 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER
DSS GDB:433750Xp21.3-Xp21.3 DOSAGE-SENSITIVE SEX REVERSAL; DSS
DYT3 GDB:118789Xq12-Xq13.1 TORSION DYSTONIA-3, X-LINKED TYPE; DYT3
EBM GDB:119102Xpter-Xqter Xq27.3-Xqter BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE
ED1 GDB:119859Xq12-Xq13.1 ECTODERMAL DYSPLASIA, ANHIDROTIC; EDA
ELK1 GDB:119867Xp11.3-Xp11.23 Xp11.2-Xp11.2 ELK1, MEMBER OF ETS ONCOGENE FAMILY; ELK1
EMD GDB:119108Xq28-Xq28 MUSCULAR DYSTROPHY, TARDIVE, DREIFUSS-EMERY TYPE, WITH CONTRACTURES
EVR2 GDB:136068Xp11.4-Xp11.3 Xp11-Xp11 Xq21.3-Xq21.3 EXUDATIVE VITREORETINOPATHY, FAMILIAL, X-LINKED RECESSIVE; EVR2
F8C GDB:119124Xq28-Xq28 HEMOPHILIA A
F9 GDB:119900Xq26.3-Xq27.1 Xq27.1-Xq27.2 HEMOPHILIA B; HEMB
FCP1 GDB:347490Xp22.3-Xp22.2 F-CELL PRODUCTION, X-LINKED; FCPX
FDPSL5 GDB:119922Xq21-Xq22 SYNTHETASE-5; FPSL5
FGD1 GDB:119131Xp11.21-Xp11.21 SYNDROME
FACIOGENITAL DYSPLASIA; FGDY
FGS1 GDB:9836950Xq12-Xq21.31 FG SYNDROME
FMR1 GDB:129038Xq27.3-Xq27.3 FRAGILE SITE MENTAL RETARDATION-1; FMR1
FMR2 GDB:141566Xq28-Xq28 FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA(X)(q28); FRAXE
G6PD GDB:120621Xq28-Xq28 GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
GABRA3 GDB:119968Xq28-Xq28 GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3; GABRA3
GATA1 GDB:125373Xp11.23-Xp11.23 GATA-BINDING PROTEIN 1; GATA1
GCP GDB:120622Xq28-Xq28 COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD; DCB
GDI1 GDB:1347097Xq28-Xq28 GDP DISSOCIATION INHIBITOR 1; GDI1
MENTAL RETARDATION, X-LINKED NONSPECIFIC, TYPE 3; MRX3
GDXY GDB:9954629Xp22.11-Xp21.2 DYSGENESIS, XY FEMALE TYPE; GDXY
GJB1 GDB:125246Xq13.1-Xq13.1 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED; CMTX1
GAP JUNCTION PROTEIN, BETA-1, 32 KD; GJB1
GK GDB:119271Xp21.3-Xp21.3 HYPERGLYCEROLEMIA
GLA GDB:119272Xq21.3-Xq22 ANGIOKERATOMA, DIFFUSE
GPC3 GDB:3770726Xq26.1-Xq26.1 GLYPICAN-3; GPC3
SIMPSON DYSMORPHIA SYNDROME; SDYS
GRPR GDB:128035Xp22.2-Xp22.13 Xp22.2-Xp22.2 GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR
GTD GDB:9954635Xp21-Xp21 GONADOTROPIN DEFICIENCY; GTD
GUST GDB:9954655Xq26-Xq26 MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES
HMS1 GDB:251827Xq28-Xq28 1; HMS1
HPRT1 GDB:119317Xq26.1-Xq26.1 HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1
HPT GDB:119322Xq26-Xq27 HYPOPARATHYROIDISM, X-LINKED; HYPX
HTC2 GDB:700980Xq24-Xq27.1 HYPERTRICHOSIS, CONGENITAL GENERALIZED; CGH; HCG
HTR2C GDB:378202Xq24-Xq24 5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C
HYR GDB:9954625Xp22.3-Xp22.3 REGULATOR; HYR
IDS GDB:120521Xq27.3-Xq28 Xq28-Xq28 MUCOPOLYSACCHARIDOSIS TYPE II
IHG1 GDB:119343Xpter-Xqter HYPOPLASIA OF, WITH GLAUCOMA; IHG
IL2RG GDB:134807Xq13.1-Xq13.1 INTERLEUKIN-2 RECEPTOR, GAMMA; IL2RG
INDX GDB:9954657Xq26-Xqter IMMUNONEUROLOGIC DISORDER, X-LINKED
IP1 GDB:120105Xp11.21-Xcen INCONTINENTIA PIGMENTI, TYPE I; IP1
IP2 GDB:120106Xq27-Xq28 INCONTINENTIA PIGMENTI, TYPE II; IP2
JMS GDB:204055Xq12-Xq21 MENTAL RETARDATION, X-LINKED, WITH GROWTH RETARDATION, DEAFNESS, AND
KAL1 GDB:120116Xp22.32-Xp22.32 KALLMANN SYNDROME 1; KAL1
KFSD GDB:128174Xp22.2-Xp21.2 Xp22.2-Xp22.13 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI; KFSD
L1CAM GDB:120133Xq28-Xq28 CLASPED THUMB AND MENTAL RETARDATION
L1 CELL ADHESION MOLECULE; L1CAM
LAMP2 GDB:125376Xq24-Xq24 LYSOSOME-ASSOCIATED MEMBRANE PROTEIN B; LAMP2; LAMPB
MAA GDB:119372Xpter-Xqter MICROPHTHALMIA OR ANOPHTHALMOS, WITH ASSOCIATED ANOMALIES; MAA
MAFD2 GDB:119373Xq27-Xq28 PSYCHOSIS, X-LINKED
MAOA GDB:120164Xp11.4-Xp11.3 Xp11.23-Xp11.23 MONOAMINE OXIDASE A; MAOA
MAOB GDB:119377Xp11.4-Xp11.3 Xp11.23-Xp11.23 MONOAMINE OXIDASE B; MAOB
MCF2 GDB:120168Xq26.3-Xq27.1 MCF.2 CELL LINE DERIVED TRANSFORMING SEQUENCE; MCF2
MCS GDB:128370Xq13-Xq22 MENTAL RETARDATION, X-LINKED, SYNDROMIC-4, WITH CONGENITAL CONTRACTURES
MEAX GDB:119383Xpter-Xqter X-LINKED, WITH EXCESSIVE AUTOPHAGY; XMEA; MEAX
MECP2 GDB:3851454Xq28-Xq28
SYNDROME; RTT
MF4 GDB:119386Xpter-Xqter METACARPAL 4-5 FUSION; MF4
MGC1 GDB:120179Xq13.3-Xq25 MEGALOCORNEA; MGC1; MGCN
MIC5 GDB:120526Xq27-Xq28 SURFACE ANTIGEN, X-LINKED; SAX
MID1 GDB:9772232Xp22-Xp22 Xp22.3-Xp22.3 OPITZ SYNDROME
MLLT7 GDB:392309Xq13-Xq13 MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA, TRANSLOCATED TO, 7; MLLT7
MLS GDB:262123Xp22-Xp22 MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS
MRSD GDB:119398Xq27-Xq28 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD
MRX14 GDB:138453Xp11-Xq13 RETARDATION, X-LINKED 14; MRX14
MRX1 GDB:120193Xp11-Xq13 MENTAL RETARDATION, X-LINKED NONSPECIFIC, TYPE 1; MRX1
MRX20 GDB:217050Xp11.3-Xp11.23 MENTAL RETARDATION, X-LINKED 20; MRX20
MRX2 GDB:120194Xp22.3-Xp22.2 RETARDATION, X-LINKED NONSPECIFIC, TYPE 2; MRX2
MRX3 GDB:128105Xq28-Xq28 GDP DISSOCIATION INHIBITOR 1; GDI1
MENTAL RETARDATION, X-LINKED NONSPECIFIC, TYPE 3; MRX3
MRX40 GDB:700754Xq21.1-Xq21.1 MENTAL RETARDATION, X-LINKED, WITH HYPOTONIA
MRXA GDB:9954641Xp11-Xp11 MENTAL RETARDATION, X-LINKED NONSPECIFIC, WITH APHASIA; MRXA
MSD GDB:119399Xpter-Xqter SYNDROME
MTM1 GDB:119439Xq27.3-Xq28 Xq28-Xq28 MYOTUBULAR MYOPATHY 1; MTM1
MYCL2 GDB:120209Xq22-Xq28 MYCL-RELATED PROCESSED GENE; MYCL2
MYP1 GDB:127783Xpter-Xqter Xq28-Xq28 MYOPIA, X-LINKED; MYP1
NDP GDB:119449Xp11.4-Xp11.3 Xp11.4-Xp11.4 NORRIE DISEASE; NDP
NHS GDB:120235Xp22.3-Xp21.1 CATARACT-DENTAL SYNDROME
NPHL1 GDB:433705Xp11.4-Xp11.3 NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN
NR0B1 GDB:118982Xp21.3-Xp21.3 ADRENAL HYPOPLASIA, CONGENITAL; AHC
NSX GDB:125596Xpter-Xqter SYNDROME; NSX
NYS1 GDB:119458Xpter-Xqter NYSTAGMUS, X-LINKED; NYS
OA1 GDB:119459Xp22.3-Xp22.3 ALBINISM, OCULAR, TYPE 1; OA1
OASD GDB:138457Xp22.3-Xp22.3 OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD
OCRL GDB:119461Xq25-Xq26.1 Xq26.1-Xq26.1 LOWE OCULOCEREBRORENAL SYNDROME; OCRL
ODT1 GDB:125360Xpter-Xqter TEETH, ABSENCE OF
OFD1 GDB:120248Xpter-Xqter Xp22.3-Xp22.2 OROFACIODIGITAL SYNDROME 1; OFD1
OPA2 GDB:125358Xpter-Xqter Xp11.4-Xp11.2 OPTIC ATROPHY 2; OPA2
OPD1 GDB:120249Xq26-Xq28 OTOPALATODIGITAL SYNDROME
OPEM GDB:119467Xpter-Xqter OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM
OTC GDB:119468Xp21.1-Xp21.1 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
P3 GDB:9954667Xq28-Xq28 PROTEIN P3
PDHA1 GDB:118895Xp22.1-Xp22.1 PYRUVATE DEHYDROGENASE COMPLEX, E1-ALPHA POLYPEPTIDE-1; PDHA1
PDR GDB:203409Xp22-Xp21 AMYLOIDOSIS, FAMILIAL CUTANEOUS
PFC GDB:120275Xp11.3-Xp11.23 PROPERDIN DEFICIENCY, X-LINKED
PFKFB1 GDB:125375Xcen-Xq13 Xpter-Xqter Xp11.21-Xp11.21 6-@PHOSPHOFRUCTO-2-KINASE; PFKFB1
PGK1 GDB:120282Xq13.3-Xq13.3 PHOSPHOGLYCERATE KINASE 1; PGK1
PGS GDB:128372Xq25-Xq27 DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE,
PHEX GDB:120520Xp22.2-Xp22.1 HYPOPHOSPHATEMIA, VITAMIN D-RESISTANT RICKETS; HYP
PHKA1 GDB:120285Xq13.1-Xq13.1 PHOSPHORYLASE KINASE, ALPHA 1 SUBUNIT (MUSCLE); PHKA1
PHKA2 GDB:127279Xp22.2-Xp22.1 GLYCOGEN STORAGE DISEASE VIII
PHP GDB:119494Xp21.1-Xp11.2 PANHYPOPITUITARISM; PHP
PIGA GDB:138138Xp22.1-Xp22.1 PHOSPHATIDYLINOSITOL GLYCAN, CLASS A; PIGA
PLP1 GDB:120302Xq22-Xq22 Xq21.33-Xq22 Xq22.1-Xq22.2 PROTEOLIPID PROTEIN, MYELIN; PLP
POF1 GDB:120716Xq26.1-Xq27 PREMATURE OVARIAN FAILURE 1; POF1
POLA GDB:120304Xp22.1-Xp21.3 POLYMERASE, DNA, ALPHA; POLA
PPMX GDB:9954669Xq28-Xq28 RETARDATION WITH PSYCHOSIS, PYRAMIDAL SIGNS, AND MACROORCHIDISM
PRD GDB:371323Xp11.3-Xp11.23 DYSPLASIA, PRIMARY
PRPS1 GDB:120318Xq21-Xq27 Xq22-Xq24 PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-I; PRPS1
PRPS2 GDB:120320Xp22.3-Xp22.2 PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-II; PRPS2
PRS GDB:128368Xp21-Xp11 MENTAL RETARDATION, X-LINKED, SYNDROMIC-2, WITH DYSMORPHISM AND CEREBRAL
PRTS GDB:128367Xpter-Xp21 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS
PSF2 GDB:119519Xpter-Xq13 TRANSPORTER 2, ABC; TAP2
RCP GDB:120724Xq28-Xq28 COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP
RENBP GDB:133792Xq28-Xq28 RENIN-BINDING PROTEIN; RENBP
RENS1 GDB:9806348Xp11.4-Xp11.2 MENTAL RETARDATION, X-LINKED, RENPENNING TYPE
RP2 GDB:120353Xp11.4-Xp11.23 Xp11.3-Xp11.23 RETINITIS PIGMENTOSA-2; RP2
RP6 GDB:125381Xp21.3-Xp21.2 PIGMENTOSA-6; RP6
RPGR GDB:118736Xp21.1-Xp21.1 RETINITIS PIGMENTOSA-3; RP3
RPS4X GDB:128115Xq13.1-Xq13.1 RIBOSOMAL PROTEIN S4, X-LINKED; RPS4X
RPS6KA3 GDB:365648Xp22.2-Xp22.2 RIBOSOMAL PROTEIN S6 KINASE, 90 KD, POLYPEPTIDE 3; RPS6KA3
RS1 GDB:119581Xp22.2-Xp22.1 RETINOSCHISIS; RS
S11 GDB:120361Xq26-Xq28 ANTIGEN, X-LINKED, SECOND; SAX2
SDYS GDB:119590Xq26-Xq26 GLYPICAN-3; GPC3
SIMPSON DYSMORPHIA SYNDROME; SDYS
SEDL GDB:120372Xp22-Xp22 SPONDYLOEPIPHYSEAL DYSPLASIA, LATE; SEDL
SH2D1A GDB:120701Xq25-Xq25 IMMUNODEFICIENCY, X-LINKED PROGRESSIVE COMBINED VARIABLE
SHFM2 GDB:226635Xq26-Xq26 SPLIT-HAND/SPLIT-FOOT ANOMALY, X-LINKED
SHOX GDB:6118451Xp22.32-Xp22.32 SHORT STATURE; SS
SLC25A5 GDB:125190Xq13-Xq26 Xq24-Xq25 ADENINE NUCLEOTIDE TRANSLOCATOR 2; ANT2
SMAX2 GDB:9954643Xp-Xp SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE
SRPX GDB:3811398Xp21.1-Xp21.1 RETINITIS PIGMENTOSA-3; RP3
SRS GDB:136337Xp21-Xp21 MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE
STS GDB:120393Xp22.32-Xp22.32 ICHTHYOSIS, X-LINKED
SYN1 GDB:119606Xp11.23-Xp11.23 SYNAPSIN I; SYN1
SYP GDB:125295Xp11.23-Xp11.22 SYNAPTOPHYSIN; SYP
TAF2A GDB:120573Xq13-Xq26 Xq13.1-Xq13.1 TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR 2A; TAF2A
TAZ GDB:120609Xq28-Xq28 CARDIOMYOPATHY, DILATED 3A; CMD3A
ENDOCARDIAL FIBROELASTOSIS-2; EFE2
TBG GDB:120399Xq21.3-Xq22.2 Xq21-Xq22 Xq22-Xq22 THYROXINE-BINDING GLOBULIN OF SERUM; TBG
TDD GDB:119610Xpter-Xqter MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE;
TFE3 GDB:125870Xp11.23-Xp11.22 TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER-3; TFE3
THAS GDB:128158Xpter-Xqter THORACOABDOMINAL SYNDROME; TAS
THC GDB:125361Xp21-Xp11 THROMBOCYTOPENIA, X-LINKED; THC; XLT
TIMM8A GDB:119090Xq21-Xq22 Xq22-Xq22 Xq21.3-Xq22 DEAFNESS 1, PROGRESSIVE; DFN1
TIMP1 GDB:119615Xp11.3-Xp11.23 TISSUE INHIBITOR OF METALLOPROTEINASE-1; TIMP1
TKCR GDB:119616Xq28-Xqter TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKC
TNFSF5 GDB:120632Xq26-Xq26 Xq26-Xq27.2 IMMUNODEFICIENCY WITH INCREASED IgM
UBE1 GDB:118954Xp11.3-Xp11.23 Xp11.23-Xp11.23 UBIQUITIN-ACTIVATING ENZYME 1; UBE1
UBE2A GDB:131647Xq24-Xq25 UBIQUITIN-CONJUGATING ENZYME E2A; UBE2A
WAS GDB:120736Xp11.3-Xp11.22 Xp11.23-Xp11.22 WISKOTT-ALDRICH SYNDROME; WAS
WSN GDB:125864Xq27-Xqter PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION
WTS GDB:128373Xp11.3-Xq21 MENTAL RETARDATION, X-LINKED, SYNDROMIC-6, WITH GYNECOMASTIA AND OBESITY;
WWS GDB:120497Xq11-Xq22 WIEACKER SYNDROME
XIC GDB:120498Xq13.2-Xq13.2 X-INACTIVATION-SPECIFIC TRANSCRIPT; XIST
XIST GDB:126428Xq13.2-Xq13.2 X-INACTIVATION-SPECIFIC TRANSCRIPT; XIST
XK GDB:120499Xp21.1-Xp21.1 Xk LOCUS
XM GDB:119634Xpter-Xqter XM SYSTEM
XS GDB:119636Xp21.2-Xq21.1 LUTHERAN SUPPRESSOR, X-LINKED; XS; LUXS
ZFX GDB:120502Xp22.1-Xp22.1 ZINC FINGER PROTEIN, X-LINKED; ZFX
ZIC3 GDB:249141Xq24-Xq27.1 Xq26-Xq26 HETEROTAXY, X-LINKED VISCERAL; HTX1
ZNF41 GDB:125865Xp11.3-Xp11.23 ZINC FINGER PROTEIN-41; ZNF41
ZNF6 GDB:120508Xq21.1-Xq21.3 Xq21.1-Xq21.1 ZINC FINGER PROTEIN-6; ZNF6